Harvard Business Review

SEPTEMBER 14, 2011

Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market. In recent years, Indian firms such as Dr Reddy's have also started globalizing their R&D footprint by moving into Western markets.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

DECEMBER 13, 2017

Con: Breakthrough innovation may not get greenlit; time-to-market may seem to lag (though I’d argue what’s released is far better aligned with customer needs and more likely to successfully scale). and of course the compensation and benefits.

Productivity 8

Productivity Products Core Competence Management 8

Harvard Business Review

OCTOBER 20, 2011

And in terms of its effects on managerial decision-making, the new system should create feedback and incentives that nudge managers toward innovating for tomorrow's world, not optimizing for today's. An innovation-based measure would lead to an acceleration in investment with positive benefits for growth. As the late C.

ROE 12

ROE Debt to Equity Ratio Innovation Incentives 12